tiprankstipranks
Trending News
More News >
BioNTech SE (BNTX)
NASDAQ:BNTX
US Market

BioNTech SE (BNTX) Income Statement

Compare
4,834 Followers

BioNTech SE Income Statement

Last quarter (Q4 2025), BioNTech SE's total revenue was €898.89M, a decrease of -24.46% from the same quarter last year. In Q4, BioNTech SE's net income was €-302.14M. See BioNTech SE’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 2.76B€ 2.75B€ 3.82B€ 17.31B€ 18.98B
Gross Profit
€ 2.14B€ 2.21B€ 3.22B€ 14.32B€ 16.07B
Operating Expenses
€ 2.76B€ 3.52B€ 2.53B€ 1.67B€ 781.40M
Depreciation and Amortization
€ 367.69M€ 298.00M€ 183.40M€ 123.30M€ 75.20M
EBITDA
€ -256.17M€ -367.10M€ 1.38B€ 13.10B€ 15.00B
Operating Income
€ -623.87M€ -1.31B€ 690.40M€ 12.64B€ 15.28B
Other Income/Expenses
€ -385.46M€ 636.60M€ 495.70M€ 311.40M€ -237.40M
Pretax Income
€ -1.01B€ -677.70M€ 1.19B€ 12.95B€ 15.05B
Net Income
€ -1.09B€ -665.30M€ 930.30M€ 9.43B€ 10.29B
Per Share Metrics
Basic EPS
€ -4.51€ -2.77€ 3.87€ 38.08€ 43.87
Diluted EPS
€ -4.51€ -2.77€ 3.83€ 37.09€ 41.21
Weighted Average Shares Outstanding
241.70M 240.40M 240.60M 243.30M 244.00M
Weighted Average Shares Outstanding (Diluted)
241.70M 240.40M 242.70M 249.80M 259.70M
Currency in EUR

BioNTech SE Earnings and Revenue History